Clinical Trials Logo

Clinical Trial Summary

The proposed research intends to randomize 50 abstinent pregnant Black or Hispanic smokers to receive either the attentional retraining (AR) or control VP task. Participants will be asked to carry around a smartphone as they go about their daily lives for 2 weeks in their last month of pregnancy (Phase 1). The smartphone will sound an alert randomly during the day, at which time participants will be asked to respond to a short set of questions assessing subjective states; this will be followed by a request to complete the AR (or control) procedures. This same procedure will be repeated for 2 weeks immediately after delivery (Phase 2). Women will undergo a follow-up visit 3 months after the end of Phase 2, and complete an unmodified VP and follow-up assessments.


Clinical Trial Description

There are 2 specific aims that this study intends to address. Specific Aim 1: To examine whether AR delivered on a smartphone can modify attentional bias to smoking-related stimuli and craving for tobacco cigarettes. Specific Aim 2: To examine whether AR delivered on a smartphone can modify attentional bias to stress-related stimuli and reduce perceived stress. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04114877
Study type Interventional
Source Yale University
Contact
Status Completed
Phase N/A
Start date November 18, 2020
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT05711225 - Transtheoretic Model, Postpartum Smoking Relapse, Smoking Cessation Intervention N/A
Recruiting NCT04098874 - Bupropion for the Prevention of Postpartum Smoking Relapse Phase 4